InvestorsObserver
Sign Up Login

SPPI Spectrum Pharma Inc

$1.35 $0.12 (9.67%)
Add to Watchlist Compare
Overall

SPPI Stock Analysis Overview

What this means: Spectrum Pharma Inc (SPPI) gets an Overall Rank of 72, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. SPPI's 72 means that it ranks higher than 72% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

SPPI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

SPPI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

SPPI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

SPPI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

SPPI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

SPPI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

SPPI Stock Analysis Overview

What this means: Spectrum Pharma Inc (SPPI) gets an Overall Rank of 72, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. SPPI's 72 means that it ranks higher than 72% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full SPPI report

SPPI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

SPPI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

SPPI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

SPPI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

SPPI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

SPPI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Spectrum Pharma Inc (SPPI) Analyst Forecast

SPPI Price, Volume, Earnings, and Dividend Date

  • Last Price $1.35
  • Previous Close $1.23
  • Change $0.12
  • Open $1.25
  • Volume 2,819,719
  • Avg. Volume (100-day) 2,223,902
  • Market Cap 253,833,487
  • Days Range 1.23 - 1.36
  • 52-week Range 0.6 - 2.53
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 11/09/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 1.950
  • PEG Ratio —

Spectrum Pharma Inc (SPPI) Company Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations.

Spectrum Pharma Inc (SPPI) Stock Chart

View Interactive SPPI chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Axsome Thera (AXSM) (AXSM) $41.86
Arcutis Biotherapeutics Inc (ARQT) (ARQT) $25.01
Savara Inc (SVRA) (SVRA) $1.63
Pliant Therapeutics Inc (PLRX) (PLRX) $19.82
Trevi Therapeutics Inc (TRVI) (TRVI) $3.76
G1 Therapeutics Inc (GTHX) (GTHX) $12.09
Verona Pharma Plc ADR (VRNA) (VRNA) $12.20
Concert Pharmaceutic (CNCE) (CNCE) $6.83
Dyne Therapeutics Inc (DYN) (DYN) $11.95
Geron Corp (GERN) (GERN) $2.06